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Triple negative breast cancer represents 15% of all breast cancers and is characterized by a 
very aggressive behavior, a scenario in which effective treatments for patients are still lacking. 
Galectin-8 (Gal-8), a tandem-repeat-type galectin, has been described as a modulator of 
cellular functions including adhesion, apoptosis, pathogen recognition, autophagy, and 
immunomodulation. Activated leukocyte cell adhesion molecule (ALCAM), a receptor for 
endogenous Gal-8, is a member of the immunoglobulin superfamily involved in cell-cell 
adhesion. In this work, we explored ALCAM-Gal-8 interactions and their physiologic relevance 
in triple negative breast cancer. We found that ALCAM silencing in MDA-MB-231 breast cancer 
cells decreases cell adhesion and migration onto Gal-8-coated surfaces in a glycan-dependent 
manner. ALCAM N-glycome analysis revealed a major proportion of complex N-glycans, with 
prevalent bi- or tri-antennary structures, presented no sulfation and around 30% of sialylated 
structures. Moreover, no antenna fucosylation was detected and core fucosylated structures 
represented only 30% of complex N-glycan structures. The N-glycosylation profile of ALCAM in 
MDA-MB-231 cells resulted permissive for Gal-8 binding, and neuraminidase digestion 
considerably increased the number of structures recognized by this lectin. Furthermore, we 
found that cell sialylation is a key factor for Gal-8-mediated cell adhesion, as neuraminidase 
treatment of MDA-MB-231 significantly increased cell adhesion onto Gal-8-coated surfaces. 
Altogether, these findings demonstrate an important role for cell sialylation and, in particular, 
ALCAM sialylation in modulating MDA-MB-231 cell adhesion onto Gal-8-coated surfaces. 
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